Robert M. Davis, Chairman, CEO & President at Merck & Co., Inc. (MRK), sold 470,042 shares at $125.40 ($59.1M) on 2024-02-14, disclosed to the SEC on 2024-02-15.
Open-market sale of $59.1M MRK by Chairman, CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.74 | 124,676 | $15.7M | 26.5% |
| 2 | $125.74 | 124,676 | $15.7M | 26.5% |
| 3 | $126.37 | 25,324 | $3.2M | 5.4% |
| 4 | $126.37 | 25,324 | $3.2M | 5.4% |
| 5 | $125.40 | 85,021 | $10.7M | 18.0% |
| 6 | $125.40 | 85,021 |
| $10.7M |
| 18.0% |
| Total | $125.68 avg | 470,042 | $59.1M | 100% |
| Filing → |
| MRK | SELL | 2022-11-10 | $34.3M | — | Filing → |
| MRK | SELL | 2020-10-06 | $40.7M | — | Filing → |
| MRK | SELL | 2019-06-27 | $34.7M | — | Filing → |